NovoTek's typical workflow with our partners starts from initial market investigation all the way down to the final marketing. All processes are carried out in-house to ensure:
• Accurate and in-depth market judgment to minimize risk
• Maximally efficient internal transfer of information through all steps from regulatory to marketing
• Multiple marketing activities designed with the whole picture in mind
NovoTek's branches cover more than 70% of all hospitals and 75% of all Class III hospitals nationwide.
Current products include antibiotics, cardiovascular, G.I. tract, oncology, nutrition, and topical pharmaceuticals.
Home ⎪ About Us ⎪R&D Services ⎪ Pharmaceutical Marketing ⎪ Medical Device Marketing ⎪ Regulatory China ⎪